News

  • Coenzyme Q10: The Energizing Antioxidant

    August 1, 2000 NEW YORK, N.Y. - Noted physician, author and nutrition authority, Dr. Erika Schwartz, MD, offers valuable insights on Coenzyme Q10 in a recently released, multi-page report. As described, CoQ10 is synthesized in the body from the amino acid Tyrosine, with the help of vitamins and trace minerals. Although it is manufactured by every human body cell, not enough is produced to satisfy our daily needs. Neither can it be supplied adequately by foods such as organ meats, which contain the highest concentrations of CoQ10. Supplementation is the only practical way to fulfill the av...

    View news »
  • Antioxidant Properties: Coenzyme Q10 is being used for a variety of products

    June 1, 2000 Source: Nutritional Outlook Coenzyme Q10 has emerged as a multi-purpose ingredient, appropriate for use in a variety of products. The largest body of research shows CoQ10 may be beneficial for the heart, as studies have identified CoQ10 deficiency in many heart patients. A study by the University of Texas found that patients being treated for congestive heart failure who took CoQ10 in addition to standard therapy had a 75 percent chance of survival after three years, while those using conventional therapy only experienced a 25 percent survival rate. In Japan, CoQ10 is an appr...

    View news »
  • Kyowa Hakko USA Relocates West Coast Office

    March 1, 2000 NEW YORK, New York - Kyowa Hakko U.S.A., Inc. announced that its West Coast office has been relocated to Aliso Viejo, California. According to Kyowa's General Manager, Donald Blaine, who heads the office, the move comes in response to recent growth and will also facilitate expected future expansion. The new location is 85 Enterprise, Suite 430, Aliso Viejo, CA 92656, telephone 949-425-0707, facsimile 949-425-0708. Kyowa Hakko is among the world's leading producers and marketers of amino acids, nucleic acids, chemical intermediates, and bio-products for the pharmaceutic...

    View news »
  • Kyowa Hakko USA Offers Long-Term Toxicity Study with Natural Coenzyme Q10

    December 1, 1999 NEW YORK, New York - Kyowa Hakko U.S.A., Inc. is offering an eight-page report on an in-depth study of the long-term toxicity of Natural Coenzyme Q10 (derived from fermentation). The information was published in August, 1999 in the Journal of Agriculture and Food Chemistry. Prompted by the growing application of CoQ10 as a dietary supplement, the objective of the subject research was to rigorously test the chronic toxicity in an experimental design following principles for the safety assessment of food additives (FDA, 1982). Over a 52-week period, CoQ10 was administered d...

    View news »
  • Kyowa Hakko USA Introduces Universal Certificate of Analysis to Aid Manufacturers

    August 1, 1999 NEW YORK, New York - Kyowa Hakko U.S.A., Inc. has introduced a new reporting system designed to provide customers with comprehensive technical and quality assurance data on the company's broad range of raw materials. Kyowa Hakko's Universal Certificate of Analysis will measure materials performance based on JP, USP, EP, and FCC criteria. For over fifty years, product quality, performance and consistency have been paramount to Kyowa Hakko. The new Universal Certificate of Analysis, incorporating manufacturing specifications and product test results in a concise, uniform form...

    View news »
  • Kyowa Hakko Celebrates 50th Anniversary

    October 1, 1999 Source: Supplement Industry Executive Even as the new millennium approaches, another milestone must first be noted: the recent 50th anniversary of nutritional ingredient supplier Kyowa Hakko. Founded by Dr. Benzabro Kato in July of 1949, Kyowa Hakko is one of the world's leading manufacturer of amino acids, nucleic acids, bio-products and fine chemicals for dietary supplement, food and pharmaceutical industries. The company, which has its international headquarters in Tokyo, operates in the U.S. from a main office in New York City, with an additional West Coast office l...

    View news »
  • Kyowa Hakko Expands and Targets Amino Acids

    September 14, 1998 Company invests heavily in R&D and core technologies Source: Chemical Market Reporter New York-based Kyowa Hakko USA, Inc. is profiting from strong demand in the amino acids market, which reflects the vigorous performance of the US health food, nutrition, pharmaceuticals and fine chemicals industries. Kyowa Hakko USA, the marketing arm of Tokyo, Japan based Kyowa Kogyo Company Ltd., is supplying an increasing range of its amino acid products to the US pharmaceuticals and fine chemicals market. The strength of the chirals market is another driving force in the growth...

    View news »
  • Kyowa to Build $50 Million Seasoning Plant in Missouri

    September 14, 1998 Source: Chemical Market Reporter Construction will begin shortly on a $50 million plant in Girardeau, MO., to manufacture nucleotide seasonings for the newly formed company Kyowa Foods, Inc. The groundbreaking is expected to take place in November. The plant will have a capacity of 2,000 metric tons and employ 50 to 60 people. Nucleotides are already being produced in Japan by Kyowa Hakko Kogyo Company, Ltd., which has exported them globally for the past 10 years. The output of the new plant will double Kyowa's capacity and position it for the expected growth in the s...

    View news »
  • Spotlight On Health: Supplement Hailed By Some As Life Saver

    A vitamin-like substance found in every cell in the body may hold the answer to preventing heart disease.

    View news »
  • Spotlight On Health: Supplement Hailed By Some As Life Saver

    June 1, 1998 Source: North American Precise Syndicate, Inc. (NAPS) - A vitamin-like substance found in every cell in the body may hold the answer to preventing heart disease. Naturally present in small amounts in a wide variety of foods, CoEnzyme Q10 plays an important part in the body's production of energy. This year scientists from all over the world attended the first International CoQ10 Conference in Boston. Scientific sessions from May 21 to 24 discussed clinical studies that have demonstrated the supplement's positive impact on heart disease and aging, among other problems. ...

    View news »